DKK637.00
0.34% yesterday
Copenhagen, Jun 13, 05:00 pm CET
ISIN
DK0060448595
Symbol
COLO B
Sector

Coloplast A/S B Stock price

DKK637.00
+2.80 0.44% 1M
-187.40 22.73% 6M
-149.20 18.98% YTD
-217.20 25.43% 1Y
-408.50 39.07% 5Y
+156.13 32.47% 10Y
+567.10 811.29% 20Y
Copenhagen, Closing price Fri, Jun 13 2025
-2.20 0.34%
ISIN
DK0060448595
Symbol
COLO B
Sector

Key metrics

Market capitalization DKK143.82b
P/E (TTM) P/E ratio 31.58
P/S ratio (TTM) P/S ratio 5.17
Dividend yield 3.45%
Last dividend (FY25) DKK22.00
Revenue growth (TTM) Revenue growth 8.89%
Revenue (TTM) Revenue DKK27.79b
EBIT (operating result TTM) EBIT DKK7.48b
Free Cash Flow (TTM) Free Cash Flow DKK4.87b
EPS (TTM) EPS DKK20.17
P/E forward 34.96
P/S forward 5.08
Show more

Is Coloplast A/S B a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,847 stocks worldwide.

Coloplast A/S B Stock Analysis

Unlock Scores for Free

Analyst Opinions

24 Analysts have issued a Coloplast A/S B forecast:

6x Buy
25%
16x Hold
67%
2x Sell
8%

Analyst Opinions

24 Analysts have issued a Coloplast A/S B forecast:

Buy
25%
Hold
67%
Sell
8%

Financial data from Coloplast A/S B

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
27,794 27,794
9% 9%
100%
- Direct Costs 9,028 9,028
8% 8%
32%
18,766 18,766
10% 10%
68%
- Selling and Administrative Expenses 10,378 10,378
12% 12%
37%
- Research and Development Expense 917 917
2% 2%
3%
8,811 8,811
8% 8%
32%
- Depreciation and Amortization 1,335 1,335
14% 14%
5%
EBIT (Operating Income) EBIT 7,476 7,476
7% 7%
27%
Net Profit 4,544 4,544
8% 8%
16%

In millions DKK.

Don't miss a Thing! We will send you all news about Coloplast A/S B directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Coloplast A/S develops, manufactures, and markets medical products. It operates through the following segments: Chronic Care, Interventional Urology and Wound & Skin Care. The Chronic Care segment covers the sale of ostomy care products and continence care products. The Interventional Urology segment covers the sale of urological products, including disposable products. The Wound & Skin Care segment covers the sale of wound and skin care products. The company was founded by Aage Louis-Hansen and Johanne Louise-Hansen in 1954 and is headquartered in Humlebaek, Denmark.

Head office Denmark
CEO Lars Rasmussen
Employees 16,628
Founded 1957
Website www.coloplast.dk

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today